PHP
ARVN icon

Parkman Healthcare Partners’s Arvinas ARVN Stock Holding History

Parkman Healthcare Partners’s Portfolio ARVN Stock Details ARVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-106,871
Closed -$2.05M – 93
2024
Q4 		$2.05M Buy
106,871
+10,688
+11% +$260K 0.27% 70
2024
Q3 		$2.37M Sell
96,183
-28,978
-23% -$757K 0.3% 71
2024
Q2 		$3.33M Buy
125,161
+182
+0.1% +$5.8K 0.45% 63
2024
Q1 		$5.16M Sell
124,979
-42,022
-25% -$1.84M 0.63% 51
2023
Q4 		$6.87M Buy
167,001
+62,884
+60% +$1.47M 0.97% 34
2023
Q3 		$2.04M Buy
104,117
+4,117
+4% +$101K 0.37% 72
2023
Q2 		$2.48M Buy
+100,000
New +$2.57M 0.43% 65

Other funds holding ARVN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Parkman Healthcare Partners's ARVN Position: Q1 2025 in Review

Parkman Healthcare Partners sold out of Arvinas (ARVN) in Q1 2025, closing a stake of 106,871 shares — an estimated $2.05M sold.

Parkman Healthcare Partners first reported a position in ARVN in Q2 2023 and held it in 7 quarters. The position peaked at $6.87M in Q4 2023. 215 funds tracked by Wall St. Rank hold ARVN as of Q1 2025.

  • Parkman Healthcare Partners reported no remaining Arvinas position as of Q1 2025 after selling out during the quarter.
  • Parkman Healthcare Partners sold 106,871 Arvinas shares in Q1 2025, an estimated $2.05M.
  • Parkman Healthcare Partners first reported a position in Arvinas in Q2 2023 and held it in 7 quarters.
  • Parkman Healthcare Partners's Arvinas position peaked at $6.87M in Q4 2023.
  • 215 funds tracked by Wall St. Rank held Arvinas as of Q1 2025.

Based on Parkman Healthcare Partners's 13F filing for Q1 2025, filed 15 May 2025.